2 results match your criteria: "Institute of Chronic Illness[Affiliation]"
Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe.
Biomed Res Int
February 2015
Institute of Chronic Illness, Inc., 14 Redgate Court, Silver Spring, MD 20905, USA.
Article Synopsis
- Over 165 studies have investigated the safety of Thimerosal, a mercury-based preservative in childhood vaccines, with many finding it harmful, particularly to infants and children.
- Among these studies, 16 focused on serious health outcomes like death, developmental delays, and neurodevelopmental disorders such as autism.
- The CDC maintains that Thimerosal is safe and not linked to autism, but this contradicts an internal study indicating a significant increase in autism risk associated with Thimerosal exposure in infancy, prompting a review of the CDC's findings compared to independent research.
Evaluation of regression in autism spectrum disorder based on parental reports.
N Am J Med Sci
January 2014
Department of Research, Institute of Chronic Illness, Inc., Silver Spring, Maryland.
Background: Research indicates that some children with autism spectrum disorder (ASD) experience a developmental regression.
Aims: The study examined the percentage of children with autism, pervasive developmental disorder (PDD), ASD, and Asperger syndrome (AS) who were considered to be delayed (D), regressed (R), or delayed and later regressed (DR) and examined any relationship with autism severity, time of onset, factors associated with onset, gastrointestinal (GI) symptoms, race, age, and gender.
Materials And Methods: The study reviewed developmental and medical information based on parental reports of 135 children with a diagnosis of autism, PDD, ASD, or AS.